Posts tagged Journal

Chantix, the drug manufacturer Pfizer smoking cessation, recently as the preferred and most suitable for smokers quit their nicotine addiction has been induced reported. The study results were published in the medical journal Thorax, and stated that lasted nearly 746 smokers who Chantix for 12 weeks, 56 percent of respondents remained free cigarette. The study compared the information researched the number of people remained without cigarettes while using nicotine patches, and the number unchanged at 43 percent.

The study was funded by pharmaceutical companies and was founded by Dr. Henri-Jean Aubin conducted the French hospital Emile-Roux. The study showed that during the study, which was held for over a year, were randomly given either nicotine patches individuals in prescriptions of Chantix. The researchers found that the drug was 6 percent more success in keeping smokers abstinent from cigarettes than nicotine patches after a year.

Chantix risks still widespread />
In November 2007, reports began serious psychological risks among Chantix patients surface. Side effects include depression, suicidal thoughts and behavior and suicidality. At that time, more than 30 people were committed suicide because of the side effects of drugs with almost 400 other people reporting symptoms similar reactions.

The U.S. Food and Drug Administration (FDA) began an investigation into the use of the drug and found evidence of risks. In February 2008, the FDA issued a public health advisory says the drug has an effect on severe neuropsychiatric symptoms of Chantix patients, but the drug on the market and not yet the subject has been a reminder of the dangers. In addition, nearly 37 percent of patients suffer from nausea while taking Chantix medication. Other side effects of Chantix:

Constipation * />
* Gas />
* Vomiting and nausea (most common side effect)

* Sleep disorders, including unusual / strange dreams, inability to sleep, etc.

According to Pfizer made available to patients taking other drugs such as herbal supplements, vitamins, insulin, anticoagulants and medications for asthma at risk for complications and should consult a physician about the use of prescription drugs and precedents.

Discontinuation of treatment

According to a Reuters Health news report by Dr. Paul Aveyard, said University of Birmingham, who wrote an editorial accompanying the study, the results of the study does not necessarily mean that the drug Chantix is most appropriate smoking cessation market. Aveyard explained that these drugs are usually sufficient to depend on the patient work as a drug for a patient, but not for another patient.

Other medications for smoking cessation are available for patients are as follows, according to the National Cancer Institute (NCI):

* Nicotine gum

* Nicotine inhalers

* Nicotine lozenges

* Nicotine patches

* Nicotine nasal spray

Varenicline pills *

* Bupropion SR pills

While the inhalers, gum, patches, sprays and lozenges contain nicotine and are used to contain slowly reduce the amount of use, nicotine and bupropion, varenicline no nicotine. These drugs are for people with disabilities include:

* Women who are pregnant or breast-feeding

* People with seizure

* The Eating Disorders

* People who consume heavy amounts of alcohol

It is looking for a patient to quit smoking, always recommended to consult a physician especially if they showed signs and symptoms of mood swings, behavioral problems, suicidal thoughts and tendencies and depression, while among Chantix.

Overcoming Chantix side effects

The Chantix dangers may be difficult to overcome, because it can cause severe illness of depression in patients. Because of the damage and present, are incurred when were with Chantix, Chantix victims have the potential to develop an action. Consulting with a pharmaceutical law firm can afford information on the potential of further Chantix, which are capable of a victim with monetary compensation for any damage to a patient and their families.